SBC Medical [SBC] vs Booz Allen Hamilton [BAH] Detailed Stock Comparison
SBC Medical
NASDAQ
Loading...
Booz Allen Hamilton
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: SBC Medical wins in 9 metrics, Booz Allen Hamilton wins in 10 metrics, with 0 ties. Booz Allen Hamilton appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | SBC Medical | Booz Allen Hamilton | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 13.22 | 12.78 | Booz Allen Hamilton |
| Price-to-Book Ratio | 1.78 | 12.08 | SBC Medical |
| Debt-to-Equity Ratio | 6.35 | 392.96 | SBC Medical |
| PEG Ratio | -0.15 | 0.18 | SBC Medical |
| EV/EBITDA | 3.96 | 11.23 | SBC Medical |
| Profit Margin (TTM) | 17.71% | 8.70% | SBC Medical |
| Operating Margin (TTM) | 33.57% | 10.02% | SBC Medical |
| EBITDA Margin (TTM) | 33.57% | 10.02% | SBC Medical |
| Return on Equity | 16.44% | 96.89% | Booz Allen Hamilton |
| Return on Assets (TTM) | 15.86% | 11.65% | SBC Medical |
| Free Cash Flow (TTM) | $17.17M | $911.00M | Booz Allen Hamilton |
| Dividend Yield | N/A | 1.00% | N/A |
| 1-Year Return | -45.43% | -35.34% | Booz Allen Hamilton |
| Price-to-Sales Ratio (TTM) | 2.31 | 1.07 | Booz Allen Hamilton |
| Enterprise Value | $298.96M | $16.29B | Booz Allen Hamilton |
| EV/Revenue Ratio | 1.59 | 1.36 | Booz Allen Hamilton |
| Gross Profit Margin (TTM) | 69.21% | 51.33% | SBC Medical |
| Revenue per Share (TTM) | $2 | $95 | Booz Allen Hamilton |
| Earnings per Share (Diluted) | $0.32 | $8.14 | Booz Allen Hamilton |
| Beta (Stock Volatility) | 1.29 | 0.41 | Booz Allen Hamilton |
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends
SBC Medical vs Booz Allen Hamilton Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| SBC Medical | -5.50% | -5.07% | -17.43% | -15.23% | 21.18% | -25.77% |
| Booz Allen Hamilton | 0.39% | 4.09% | 2.31% | -5.79% | -3.10% | -18.79% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| SBC Medical | -45.43% | -62.68% | -62.68% | -79.64% | -99.99% | -99.99% |
| Booz Allen Hamilton | -35.34% | 10.22% | 26.43% | 283.59% | 435.20% | 435.20% |
News Based Sentiment: SBC Medical vs Booz Allen Hamilton
SBC Medical
News based Sentiment: POSITIVE
The lifting of the trading suspension is a significant positive development for SBC Medical Group Holdings Inc., indicating a resolution of operational or compliance issues. The accompanying stock price increase, though modest, suggests a positive market reaction and improved investor confidence. This event is important as it removes a key barrier to investment and potentially unlocks future growth.
Booz Allen Hamilton
News based Sentiment: MIXED
October brought a mix of positive and neutral developments for Booz Allen Hamilton. While the Q3 revenue was slightly below expectations, the EPS beat, a significant contract win, and positive insider activity, coupled with improving analyst sentiment, suggest a cautiously optimistic outlook. The ongoing risk of a government shutdown continues to be a key factor influencing the investment story.
Performance & Financial Health Analysis: SBC Medical vs Booz Allen Hamilton
| Metric | SBC | BAH |
|---|---|---|
| Market Information | ||
| Market Cap | $456.58M | $12.84B |
| Market Cap Category | Small cap | Large cap |
| 10 Day Avg. Volume | 37,610 | 1,842,314 |
| 90 Day Avg. Volume | 59,563 | 1,722,545 |
| Last Close | $4.12 | $104.04 |
| 52 Week Range | $2.62 - $8.83 | $96.96 - $190.59 |
| % from 52W High | -53.36% | -45.41% |
| All-Time High | $49,900.00 (Jun 21, 2010) | $190.59 (Nov 04, 2024) |
| % from All-Time High | -99.99% | -45.41% |
| Growth Metrics | ||
| Quarterly Revenue Growth | -0.18% | -0.01% |
| Quarterly Earnings Growth | -0.87% | 0.64% |
| Financial Health | ||
| Profit Margin (TTM) | 0.18% | 0.09% |
| Operating Margin (TTM) | 0.34% | 0.10% |
| Return on Equity (TTM) | 0.16% | 0.97% |
| Debt to Equity (MRQ) | 6.35 | 392.96 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $2.37 | $8.61 |
| Cash per Share (MRQ) | $1.48 | $5.77 |
| Operating Cash Flow (TTM) | $-8,702,995 | $1.08B |
| Levered Free Cash Flow (TTM) | $27.51M | $851.95M |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | 1.00% |
| Last 12-Month Dividend | N/A | $1.02 |
Valuation & Enterprise Metrics Analysis: SBC Medical vs Booz Allen Hamilton
| Metric | SBC | BAH |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 13.22 | 12.78 |
| Forward P/E | 0.40 | 14.88 |
| PEG Ratio | -0.15 | 0.18 |
| Price to Sales (TTM) | 2.31 | 1.07 |
| Price to Book (MRQ) | 1.78 | 12.08 |
| Market Capitalization | ||
| Market Capitalization | $456.58M | $12.84B |
| Enterprise Value | $298.96M | $16.29B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 1.59 | 1.36 |
| Enterprise to EBITDA | 3.96 | 11.23 |
| Risk & Other Metrics | ||
| Beta | 1.29 | 0.41 |
| Book Value per Share (MRQ) | $2.37 | $8.61 |
Financial Statements Comparison: SBC Medical vs Booz Allen Hamilton
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | SBC | BAH |
|---|---|---|
| Revenue/Sales | $43.36M | $2.92B |
| Cost of Goods Sold | $13.35M | $1.42B |
| Gross Profit | $30.01M | $1.50B |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | $14.55M | $257.00M |
| EBITDA | $14.11M | $295.00M |
| Pre-Tax Income | $13.54M | $216.00M |
| Income Tax | $11.10M | $-55.00M |
| Net Income (Profit) | $2.44M | $271.00M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | SBC | BAH |
|---|---|---|
| Cash & Equivalents | $152.74M | $885.00M |
| Total Current Assets | $241.34M | $3.31B |
| Total Current Liabilities | $60.68M | $1.85B |
| Long-Term Debt | $8.40M | $4.10B |
| Total Shareholders Equity | $244.65M | $1.00B |
| Retained Earnings | $213.42M | $3.07B |
| Property, Plant & Equipment | $5.10M | $178.00M |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | SBC | BAH |
|---|---|---|
| Operating Cash Flow | $-15.20M | $315.84M |
| Capital Expenditures | $894,013 | $-24.57M |
| Free Cash Flow | $-8.85M | $194.44M |
| Debt Repayment | $-73,026 | $-220.75M |
| Common Stock Repurchase | N/A | $-314.88M |
Short Interest & Institutional Ownership Analysis
| Metric | SBC | BAH |
|---|---|---|
| Shares Short | 133,462 | 6.58M |
| Short Ratio | 2.74 | 4.42 |
| Short % of Float | 0.01% | 0.06% |
| Average Daily Volume (10 Day) | 37,610 | 1,842,314 |
| Average Daily Volume (90 Day) | 59,563 | 1,722,545 |
| Shares Outstanding | 102.75M | 124.88M |
| Float Shares | 4.55M | 121.11M |
| % Held by Insiders | 0.89% | 0.01% |
| % Held by Institutions | 0.01% | 1.00% |
Dividend Analysis & Yield Comparison: SBC Medical vs Booz Allen Hamilton
| Metric | SBC | BAH |
|---|---|---|
| Last 12-Month Dividend | N/A | $1.02 |
| Last 12-Month Dividend Yield | N/A | 1.00% |
| 3-Year Avg Annual Dividend | N/A | $1.44 |
| 3-Year Avg Dividend Yield | N/A | 0.39% |
| 3-Year Total Dividends | N/A | $4.31 |
| Ex-Dividend Date | N/A | Nov 15, 2024 |